Syöpätautien klinikka

Julkaisut 2006
Publications 2006

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Bendardaf R et al. Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.
2 Branca M et al. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
3 Branca M et al. Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer.
4 Branca M et al. Over-expression of topoisomerase IIalfa is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
5 Branca M et al. Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.
6 Branca M et al. Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.
7 Branca M et al. Upregulation of nuclear factor-kB (NF-kB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer.
8 Branca M et al. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
9 Branca M et al. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
10 Buhmeida A et al. Prognostic factors in prostate cancer.
11 Buhmeida A et al. Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.
12 Buhmeida A et al. DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.
13 Canon J-L et al. Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia.
14 Ciotti M et al. The p53 codon 72 arg/arg homozygous women in central Italy are at increased risk for HPV infections.
15 de Carvalho JJM et al. Prevalence of genital human papillomavirus infections established using different diagnostic techniques among males attending a urological clinic.
16 Di Bonito P et al. Serum antibody response to human papillomavirus (HPV) infections detected by a novel ELISA technique based on denaturated recombinant HPV16 L1, L2, E4, E6 and E7 proteins.
17 El-Nezami HS et al. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China.
18 Elzagheid A et al. E-cadherin expression significantly correlated with the response to chemotherapy in locally advanced and metastatic colorectal carcinoma.
19 Elzagheid A et al. Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?
20 Elzagheid A et al. E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.
21 Erjala K et al. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
22 Giuliani L et al. Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping.
23 Grönroos T. [18F]Fluoroerythronitroimidazole, Tumor Hypoxia and Positron Emission Tomography.
24 Grönroos T. (18F)Fluoroerythronitroimidazole, Tumor Hypoxia and Positron Emission Tomography.
25 Hussain K et al. The diagnosis of ectopic focal hyperinsulinism of infancy with (18F)-dopa positron emission tomography.
26 Ibrahim F et al. Cadmium and lead elimination in young male Chinese students. A probiotic intervention study.
27 Joensuu H et al. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
28 Jokilehto T et al. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carsinoma is associated with tumor aggressiveness.
29 Kankuri M et al. The association of immunoreactive p53 and Ki-67 with T-stage, grade, occurrence of metastases and survival in renal cell carcinoma.
30 Kauhava L et al. Population-based mammography screening results in substantial savings in treatment costs for fatal breast cancer.
31 Kauhava L et al. Mammografiaseulonta säästää rintasyövän hoitokustannuksia rintasyöpäkuolleisuuden vähentyessä.
32 Kulmala S-MA et al. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.
33 Lindholm P et al. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: A prospective phase II study.
34 Lindholm P. Pehmytkudossarkooman onkologinen hoito - mitä ja missä vaiheessa?
35 Longatto-Filho A et al. Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American screening study.
36 Luukkaa M et al. Association between high collangenase-3 expression levels and poor prognosis in patients with head and neck cancer.
37 Mattila MM et al. Androgen and fibroblast growth factor 8 (FGF8) downregulation of thrombospondin 1 (TSP1) in mouse breast cancer cells.
38 Minn H. Positroniemissiotomografia kasvaindiagnostiikassa - saadaanko odotuksille katetta?
39 Mohnike K et al. Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism.
40 Määttä JA et al. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
41 Nogueira de Souza NC et al. Interleukin-6 polymorphisms and the risk of cervical cancer.
42 Otonkoski T et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with (18F)-DOPA positron emission tomography.
43 Parvinen I et al. Service screening mammography reduces breast cancer mortality among elderly women in Turku.
44 Ristamäki R et al. Levinneen paksu- ja peräsuolisyövän hoito.
45 Ruutu M et al. Effects of 17beta-estradiol and progesterone on transcription of human papillomavirus16 E6/E7 oncogenes in CaSki and SiHa cell lines.
46 Salminen E. Palliatiivinen lääketiede kehityshaasteiden edessä.
47 Salminen E. Palliatiivisen lääketieteen tutkimusta tuettava - tietoa tarvitaan edenneen syövän hoidon tueksi.
48 Salminen E, Clemens KE. Tuulta purjeisiin palliatiivisen lääketieteen kehitysyhteistyölle Itämeren maissa.
49 Salminen E, Clemens KE. Itämeren maat tiivistävät yhteistyötä palliatiivisessa lääketieteessä.
50 Salminen E, Sipilä P. Development of cancer care and use of radiotherapy equipment in a small country - The Finnish model.
51 Salminen EK et al. Survival markers related to bone metastases in prostate cancer.
52 Salminen EK et al. Palliative chemotherapy with trofosfamide in advanced prostate cancer.
53 Santopietro R et al. Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union.
54 Schrey AR et al. Functional evaluation of microvascular free flaps with positron emission tomography.
55 Syrjänen K. Morphological diagnosis.
56 Syrjänen K. HPV and oesophageal carcinoma.
57 Syrjänen K. Molecular markers of gynaecological malignancies: Chapter editor's introduction.
58 Syrjänen K. The causal role of genital human papillomavirus (hpv) infections in cervical carcinogenesis.
59 Syrjänen K et al. Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections.
60 Tolvanen T et al. Human radiation dosimetry of (11C)MeAIB, a new tracer for imaging of system A amino acid transport.
61 von Knebel-Doeberitz M, Syrjänen KJ. Molecular markers: How to apply in practice.
62 Österlund P et al. Paksu- ja peräsuolisyövän liitännäishoito.
63 Österlund P et al. Kolorektaalisyövän hoito on monen erikoisalan yhteistyötä.
Julkaisutietokanta 23.10.2007 Publications Data Base 23.10.2007